The case in front of me: QST · tirzepatide.
The figures are clear enough; the question is what they mean and what they do not.
I can supply the numbers if the specifics change the answer.
How should I read this, and where are the traps?
Start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
| Δ mass (Da) | Most likely cause | Distinguishing feature |
|---|---|---|
| +1 | Deamidation (Asn or Gln) | New peak, slightly earlier retention |
| −17 | Loss of ammonia | Often with deamidation |
| −18 | Dehydration / succinimide | pH-dependent, reversible |
| +16 | Oxidation (Met, Trp) | Earlier retention, light-related |
| −128 | Missing Gln or Lys | Deletion sequence from synthesis |
| 0 | Isomer: racemisation or scrambling | Same mass, shifted retention |
Put another way, the field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 30 Oct 2025 by grainne_ahearn — added the method parameters
Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.
Shop standardsSpecifically, a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
The certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.
The relevant detail is that a method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
My working rule is that a document without a lot number, a method section and a test date is marketing.
In practice, the certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Concretely, reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
If the certificate does not trace to your vial, it is not evidence about your vial.
More usefully, ask whether the certificate answers the question you are actually asking, because the answer is often no.
Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
My working rule is that a document without a lot number, a method section and a test date is marketing.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.